BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 007507
(601 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|2W2H|A Chain A, Structural Basis Of Transcription Activation By The Cyclin
T1-Tat-Tar Rna Complex From Eiav
pdb|2W2H|B Chain B, Structural Basis Of Transcription Activation By The Cyclin
T1-Tat-Tar Rna Complex From Eiav
Length = 264
Score = 159 bits (401), Expect = 5e-39, Method: Compositional matrix adjust.
Identities = 90/244 (36%), Positives = 147/244 (60%), Gaps = 10/244 (4%)
Query: 33 RWYFSRREIEDSSPSRRDGIDLKKETYLRKSYCTFLQDLGMRLKVPQVTIATAIIFCHRF 92
RWYF+R ++E+S PSRR G+D KE R+ LQD+G RL V Q+TI TAI++ HRF
Sbjct: 8 RWYFTREQLENS-PSRRFGLDPDKELSYRQQAANLLQDMGQRLNVSQLTINTAIVYMHRF 66
Query: 93 FIRQSHAKNDRRTIATVCMFLAGKVEETPRPLKDVIIVSYEIIHKKDSTAPQRIRQQKEV 152
++ QS + R ++A +FLA KVEE P+ L+ VI V++ +H ++S R E
Sbjct: 67 YMIQSFTRFHRNSVAPAALFLAAKVEEQPKKLEHVIKVAHTCLHPQESLPDTR----SEA 122
Query: 153 YEQQKELILLGERVVLATLGFDLNVHHPYKPLVEAIKKFKVAQNALAQVAWNFVNDGLR- 211
Y QQ + +++ E ++L TLGF+L + HP+ +V+ + + +++ LAQ ++ + L
Sbjct: 123 YLQQVQDLVILESIILQTLGFELTIDHPHTHVVKCTQLVRASKD-LAQTSYFMATNSLHL 181
Query: 212 TSLCLQFKPHHIAAGAIFLAAKFLKVKLPSDGD-KVWWQEFD--VTPRQLEEVSNQMLEL 268
T+ LQ+ P +A I LA K+ ++P D K WW+ D VT L+E++++ L++
Sbjct: 182 TTFSLQYTPPVVACVCIHLACKWSNWEIPVSTDGKHWWEYVDATVTLELLDELTHEFLQI 241
Query: 269 YEQN 272
E+
Sbjct: 242 LEKT 245
>pdb|2PK2|A Chain A, Cyclin Box Structure Of The P-Tefb Subunit Cyclin T1
Derived From A Fusion Complex With Eiav Tat
pdb|2PK2|B Chain B, Cyclin Box Structure Of The P-Tefb Subunit Cyclin T1
Derived From A Fusion Complex With Eiav Tat
pdb|2PK2|C Chain C, Cyclin Box Structure Of The P-Tefb Subunit Cyclin T1
Derived From A Fusion Complex With Eiav Tat
pdb|2PK2|D Chain D, Cyclin Box Structure Of The P-Tefb Subunit Cyclin T1
Derived From A Fusion Complex With Eiav Tat
Length = 358
Score = 159 bits (401), Expect = 6e-39, Method: Compositional matrix adjust.
Identities = 89/244 (36%), Positives = 146/244 (59%), Gaps = 10/244 (4%)
Query: 33 RWYFSRREIEDSSPSRRDGIDLKKETYLRKSYCTFLQDLGMRLKVPQVTIATAIIFCHRF 92
RWYF+R ++E+S PSRR G+D KE R+ LQD+G RL V Q+TI TAI++ HRF
Sbjct: 11 RWYFTREQLENS-PSRRFGVDPDKELSYRQQAANLLQDMGQRLNVSQLTINTAIVYMHRF 69
Query: 93 FIRQSHAKNDRRTIATVCMFLAGKVEETPRPLKDVIIVSYEIIHKKDSTAPQRIRQQKEV 152
++ QS + ++A +FLA KVEE P+ L+ VI V++ +H ++S R E
Sbjct: 70 YMIQSFTRFPGNSVAPAALFLAAKVEEQPKKLEHVIKVAHTCLHPQESLPDTR----SEA 125
Query: 153 YEQQKELILLGERVVLATLGFDLNVHHPYKPLVEAIKKFKVAQNALAQVAWNFVNDGLR- 211
Y QQ + +++ E ++L TLGF+L + HP+ +V+ + + +++ LAQ ++ + L
Sbjct: 126 YLQQVQDLVILESIILQTLGFELTIDHPHTHVVKCTQLVRASKD-LAQTSYFMATNSLHL 184
Query: 212 TSLCLQFKPHHIAAGAIFLAAKFLKVKLPSDGD-KVWWQEFD--VTPRQLEEVSNQMLEL 268
T+ LQ+ P +A I LA K+ ++P D K WW+ D VT L+E++++ L++
Sbjct: 185 TTFSLQYTPPVVACVCIHLACKWSNWEIPVSTDGKHWWEYVDATVTLELLDELTHEFLQI 244
Query: 269 YEQN 272
E+
Sbjct: 245 LEKT 248
>pdb|3TNH|B Chain B, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNI|B Chain B, Structure Of Cdk9CYCLIN T F241L
Length = 259
Score = 156 bits (395), Expect = 3e-38, Method: Compositional matrix adjust.
Identities = 89/244 (36%), Positives = 147/244 (60%), Gaps = 10/244 (4%)
Query: 33 RWYFSRREIEDSSPSRRDGIDLKKETYLRKSYCTFLQDLGMRLKVPQVTIATAIIFCHRF 92
RWYF+R ++E+S PSRR G+D KE R+ LQD+G RL V Q+TI TAI++ HRF
Sbjct: 11 RWYFTREQLENS-PSRRFGVDPDKELSYRQQAANLLQDMGQRLNVSQLTINTAIVYMHRF 69
Query: 93 FIRQSHAKNDRRTIATVCMFLAGKVEETPRPLKDVIIVSYEIIHKKDSTAPQRIRQQKEV 152
++ QS + ++A +FLA KVEE P+ L+ VI V++ +H ++S R E
Sbjct: 70 YMIQSFTQFPGNSVAPAALFLAAKVEEQPKKLEHVIKVAHTCLHPQESLPDTR----SEA 125
Query: 153 YEQQKELILLGERVVLATLGFDLNVHHPYKPLVEAIKKFKVAQNALAQVAWNFVNDGLR- 211
Y QQ + +++ E ++L TLGF+L + HP+ +V+ + + +++ LAQ ++ + L
Sbjct: 126 YLQQVQDLVILESIILQTLGFELTIDHPHTHVVKCTQLVRASKD-LAQTSYFMATNSLHL 184
Query: 212 TSLCLQFKPHHIAAGAIFLAAKFLKVKLPSDGD-KVWWQEFD--VTPRQLEEVSNQMLEL 268
T+ LQ+ P +A I LA K+ ++P D K WW+ D VT L+E+++++L++
Sbjct: 185 TTFSLQYTPPVVACVCIHLACKWSNWEIPVSTDGKHWWEYVDATVTLELLDELTHELLQI 244
Query: 269 YEQN 272
E+
Sbjct: 245 LEKT 248
>pdb|3MI9|B Chain B, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb
pdb|3MIA|B Chain B, Crystal Structure Of Hiv-1 Tat Complexed With Atp-Bound
Human P-Tefb
Length = 266
Score = 156 bits (394), Expect = 3e-38, Method: Compositional matrix adjust.
Identities = 89/244 (36%), Positives = 146/244 (59%), Gaps = 10/244 (4%)
Query: 33 RWYFSRREIEDSSPSRRDGIDLKKETYLRKSYCTFLQDLGMRLKVPQVTIATAIIFCHRF 92
RWYF+R ++E+S PSRR G+D KE R+ LQD+G RL V Q+TI TAI++ HRF
Sbjct: 11 RWYFTREQLENS-PSRRFGVDPDKELSYRQQAANLLQDMGQRLNVSQLTINTAIVYMHRF 69
Query: 93 FIRQSHAKNDRRTIATVCMFLAGKVEETPRPLKDVIIVSYEIIHKKDSTAPQRIRQQKEV 152
++ QS + ++A +FLA KVEE P+ L+ VI V++ +H ++S R E
Sbjct: 70 YMIQSFTQFPGNSVAPAALFLAAKVEEQPKKLEHVIKVAHTCLHPQESLPDTR----SEA 125
Query: 153 YEQQKELILLGERVVLATLGFDLNVHHPYKPLVEAIKKFKVAQNALAQVAWNFVNDGLR- 211
Y QQ + +++ E ++L TLGF+L + HP+ +V+ + + +++ LAQ ++ + L
Sbjct: 126 YLQQVQDLVILESIILQTLGFELTIDHPHTHVVKCTQLVRASKD-LAQTSYFMATNSLHL 184
Query: 212 TSLCLQFKPHHIAAGAIFLAAKFLKVKLPSDGD-KVWWQEFD--VTPRQLEEVSNQMLEL 268
T+ LQ+ P +A I LA K+ ++P D K WW+ D VT L+E++++ L++
Sbjct: 185 TTFSLQYTPPVVACVCIHLACKWSNWEIPVSTDGKHWWEYVDATVTLELLDELTHEFLQI 244
Query: 269 YEQN 272
E+
Sbjct: 245 LEKT 248
>pdb|3BLH|B Chain B, Crystal Structure Of Human Cdk9CYCLINT1
pdb|3BLQ|B Chain B, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
ATP
pdb|3BLR|B Chain B, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
Flavopiridol
pdb|3MY1|B Chain B, Structure Of Cdk9CYCLINT1 IN COMPLEX WITH DRB
pdb|3LQ5|B Chain B, Structure Of Cdk9CYCLINT IN COMPLEX WITH S-Cr8
pdb|3TN8|B Chain B, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|4EC8|B Chain B, Structure Of Full Length Cdk9 In Complex With Cyclint And
Drb
pdb|4EC9|B Chain B, Crystal Structure Of Full-Length Cdk9 In Complex With
Cyclin T
pdb|4BCF|B Chain B, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCH|B Chain B, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCI|B Chain B, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCJ|B Chain B, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 260
Score = 154 bits (390), Expect = 1e-37, Method: Compositional matrix adjust.
Identities = 88/244 (36%), Positives = 146/244 (59%), Gaps = 10/244 (4%)
Query: 33 RWYFSRREIEDSSPSRRDGIDLKKETYLRKSYCTFLQDLGMRLKVPQVTIATAIIFCHRF 92
RWYF+R ++E+S PSRR G+D KE R+ LQD+G RL V Q+TI TAI++ HRF
Sbjct: 12 RWYFTREQLENS-PSRRFGVDPDKELSYRQQAANLLQDMGQRLNVSQLTINTAIVYMHRF 70
Query: 93 FIRQSHAKNDRRTIATVCMFLAGKVEETPRPLKDVIIVSYEIIHKKDSTAPQRIRQQKEV 152
++ QS + ++A +FLA KVE P+ L+ VI V++ +H ++S R E
Sbjct: 71 YMIQSFTRFPGNSVAPAALFLAAKVEGQPKKLEHVIKVAHTCLHPQESLPDTR----SEA 126
Query: 153 YEQQKELILLGERVVLATLGFDLNVHHPYKPLVEAIKKFKVAQNALAQVAWNFVNDGLR- 211
Y QQ + +++ E ++L TLGF+L + HP+ +V+ + + +++ LAQ ++ + L
Sbjct: 127 YLQQVQDLVILESIILQTLGFELTIDHPHTHVVKCTQLVRASKD-LAQTSYFMATNSLHL 185
Query: 212 TSLCLQFKPHHIAAGAIFLAAKFLKVKLPSDGD-KVWWQEFD--VTPRQLEEVSNQMLEL 268
T+ LQ+ P +A I LA K+ ++P D K WW+ D VT L+E+++++L++
Sbjct: 186 TTFSLQYTPPVVACVCIHLACKWSNWEIPVSTDGKHWWEYVDATVTLELLDELTHELLQI 245
Query: 269 YEQN 272
E+
Sbjct: 246 LEKT 249
>pdb|2IVX|A Chain A, Crystal Structure Of Human Cyclin T2 At 1.8 A Resolution
(Casp Target)
pdb|2IVX|B Chain B, Crystal Structure Of Human Cyclin T2 At 1.8 A Resolution
(Casp Target)
Length = 257
Score = 152 bits (383), Expect = 8e-37, Method: Compositional matrix adjust.
Identities = 85/245 (34%), Positives = 148/245 (60%), Gaps = 10/245 (4%)
Query: 32 ARWYFSRREIEDSSPSRRDGIDLKKETYLRKSYCTFLQDLGMRLKVPQVTIATAIIFCHR 91
+RW+F+R ++E++ PSRR G++ KE R+ +Q++G RL V Q+TI TAI++ HR
Sbjct: 3 SRWFFTREQLENT-PSRRCGVEADKELSCRQQAANLIQEMGQRLNVSQLTINTAIVYMHR 61
Query: 92 FFIRQSHAKNDRRTIATVCMFLAGKVEETPRPLKDVIIVSYEIIHKKDSTAPQRIRQQKE 151
F++ S K ++ I++ +FLA KVEE R L+ VI V++ +H + P +
Sbjct: 62 FYMHHSFTKFNKNIISSTALFLAAKVEEQARKLEHVIKVAHACLHPLE---PLLDTKCDA 118
Query: 152 VYEQQKELILLGERVVLATLGFDLNVHHPYKPLVEAIKKFKVAQNALAQVAWNFVNDGLR 211
+Q +EL++L E ++L TLGF++ + HP+ +V+ + + +++ LAQ ++ + L
Sbjct: 119 YLQQTRELVIL-ETIMLQTLGFEITIEHPHTDVVKCTQLVRASKD-LAQTSYFMATNSLH 176
Query: 212 -TSLCLQFKPHHIAAGAIFLAAKFLKVKLPSDGD-KVWWQEFD--VTPRQLEEVSNQMLE 267
T+ CLQ+KP IA I LA K+ ++P D K WW+ D VT L+E++++ L+
Sbjct: 177 LTTFCLQYKPTVIACVCIHLACKWSNWEIPVSTDGKHWWEYVDPTVTLELLDELTHEFLQ 236
Query: 268 LYEQN 272
+ E+
Sbjct: 237 ILEKT 241
>pdb|2I53|A Chain A, Crystal Structure Of Cyclin K
Length = 258
Score = 150 bits (380), Expect = 1e-36, Method: Compositional matrix adjust.
Identities = 87/249 (34%), Positives = 142/249 (57%), Gaps = 19/249 (7%)
Query: 34 WYFSRREIEDSSPSRRDGIDLKKETYLRKSYCTFLQDLGMRLKVPQVTIATAIIFCHRFF 93
WY+ ++++ +PS+ +G+D E R+ F+ D+G RL + T+AT II+ HRF+
Sbjct: 15 WYWDKKDLA-HTPSQLEGLDPATEARYRREGARFIFDVGTRLGLHYDTLATGIIYFHRFY 73
Query: 94 IRQSHAKNDRRTIATVCMFLAGKVEETPRPLKDVIIVSYEIIHKKDSTAPQRIRQQKEVY 153
+ S + R C+FLAGKVEETP+ KD+I + +++ Q +
Sbjct: 74 MFHSFKQFPRYVTGACCLFLAGKVEETPKKCKDIIKTARSLLNDV---------QFGQFG 124
Query: 154 EQQKELILLGERVVLATLGFDLNVHHPYKPLVEAIKKFKVAQN---ALAQVAWNFVNDGL 210
+ KE +++ ER++L T+ FDL V HPY+ L++ K+ K +N L Q+AW FVND L
Sbjct: 125 DDPKEEVMVLERILLQTIKFDLQVEHPYQFLLKYAKQLKGDKNKIQKLVQMAWTFVNDSL 184
Query: 211 RTSLCLQFKPHHIAAGAIFLAAKFLKVKLPSDGDKV----WWQEF--DVTPRQLEEVSNQ 264
T+L LQ++P IA ++LA + K ++ K WW++F DV LE++ +Q
Sbjct: 185 CTTLSLQWEPEIIAVAVMYLAGRLCKFEIQEWTSKPMYRRWWEQFVQDVPVDVLEDICHQ 244
Query: 265 MLELYEQNR 273
+L+LY Q +
Sbjct: 245 ILDLYSQGK 253
>pdb|3RGF|B Chain B, Crystal Structure Of Human Cdk8CYCC
Length = 285
Score = 89.4 bits (220), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 72/232 (31%), Positives = 109/232 (46%), Gaps = 25/232 (10%)
Query: 48 RRDGIDLKKETY--LRKSYCTFLQDLGMRLKVPQVTIATAIIFCHRFFIRQSHAKNDRRT 105
++D L +E Y L+ + +Q LG LK+ Q IATA ++ RF+ R S D
Sbjct: 28 QKDLKFLSEEEYWKLQIFFTNVIQALGEHLKLRQQVIATATVYFKRFYARYSLKSIDPVL 87
Query: 106 IATVCMFLAGKVEETPRPLKDVIIVSYEIIHKKDSTAPQRIRQQKEVYEQQKEL------ 159
+A C+FLA KVEE ++ + +I S R Y KE
Sbjct: 88 MAPTCVFLASKVEEFG------VVSNTRLIAAATSVLKTRFS-----YAFPKEFPYRMNH 136
Query: 160 ILLGERVVLATLGFDLNVHHPYKPLVEAIKKFKVAQNALAQVAWNFVNDGLRTSLCLQFK 219
IL E +L + L V+HPY+PL++ ++ ++ L +AW VND RT LCL +
Sbjct: 137 ILECEFYLLELMDCCLIVYHPYRPLLQYVQDMG-QEDMLLPLAWRIVNDTYRTDLCLLYP 195
Query: 220 PHHIAAGAIFLAAKFLKVKLPSDGDKVWWQEFDVTPRQLEEVSNQMLELYEQ 271
P IA + +A V D + W+ E V ++ E+ +L+LYEQ
Sbjct: 196 PFMIALACLHVAC----VVQQKDARQ-WFAELSVDMEKILEIIRVILKLYEQ 242
>pdb|1ZP2|A Chain A, Structure Of The Mediator Subunit Cyclin C
Length = 235
Score = 66.2 bits (160), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 46/167 (27%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 68 LQDLGMRLKVPQVTIATAIIFCHRFFIRQSHAKN-DRRTIATVCMFLAGKVEETPRPLKD 126
+Q G RL++ Q +ATAI+ R+ ++++ K + C++L+ KVEE P ++
Sbjct: 35 VQTFGDRLRLRQRVLATAIVLLRRYMLKKNEEKGFSLEALVATCIYLSCKVEECPVHIRT 94
Query: 127 VIIVSYEIIHKKDSTAPQRIRQQKE-VYEQQKELILLGERVVLATLGFDLNVHHPYKPLV 185
I ++ + +++ + + E + E+I + L L VHHPY L
Sbjct: 95 -------ICNEANDLWSLKVKLSRSNISEIEFEII--------SVLDAFLIVHHPYTSLE 139
Query: 186 EAIKKFKVAQNALAQVAWNFVNDGLRTSLCLQFKPHHIAAGAIFLAA 232
+A + Q L + AW+ VND +SLCL PH +A A+ ++
Sbjct: 140 QAFHDGIINQKQL-EFAWSIVNDSYASSLCLMAHPHQLAYAALLISC 185
>pdb|1KXU|A Chain A, Cyclin H, A Positive Regulatory Subunit Of Cdk Activating
Kinase
Length = 333
Score = 58.2 bits (139), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 27/165 (16%)
Query: 77 VPQVTIATAIIFCHRFFIRQSHAKNDRRTIATVCMFLAGKVEETPRPLKDVIIVSYEIIH 136
+P+ + TA ++ RF++ S + R I C FLA KV+E
Sbjct: 85 MPRSVVGTACMYFKRFYLNNSVMEYHPRIIMLTCAFLACKVDEF---------------- 128
Query: 137 KKDSTAPQRIRQQKEV---YEQQKELILLGERVVLATLGFDLNVHHPYKP----LVEAIK 189
+ ++PQ + +E E+ E IL E +++ L F L VH+PY+P L++
Sbjct: 129 --NVSSPQFVGNLRESPLGQEKALEQILEYELLLIQQLNFHLIVHNPYRPFEGFLIDLKT 186
Query: 190 KFKVAQN--ALAQVAWNFVNDGLRTSLCLQFKPHHIAAGAIFLAA 232
++ + +N L + A +F+N T L + P IA AI +A
Sbjct: 187 RYPILENPEILRKTADDFLNRIALTDAYLLYTPSQIALTAILSSA 231
>pdb|1JKW|A Chain A, Structure Of Cyclin Mcs2
Length = 323
Score = 58.2 bits (139), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 27/165 (16%)
Query: 77 VPQVTIATAIIFCHRFFIRQSHAKNDRRTIATVCMFLAGKVEETPRPLKDVIIVSYEIIH 136
+P+ + TA ++ RF++ S + R I C FLA KV+E
Sbjct: 75 MPRSVVGTACMYFKRFYLNNSVMEYHPRIIMLTCAFLACKVDEF---------------- 118
Query: 137 KKDSTAPQRIRQQKEV---YEQQKELILLGERVVLATLGFDLNVHHPYKP----LVEAIK 189
+ ++PQ + +E E+ E IL E +++ L F L VH+PY+P L++
Sbjct: 119 --NVSSPQFVGNLRESPLGQEKALEQILEYELLLIQQLNFHLIVHNPYRPFEGFLIDLKT 176
Query: 190 KFKVAQN--ALAQVAWNFVNDGLRTSLCLQFKPHHIAAGAIFLAA 232
++ + +N L + A +F+N T L + P IA AI +A
Sbjct: 177 RYPILENPEILRKTADDFLNRIALTDAYLLYTPSQIALTAILSSA 221
>pdb|2B9R|A Chain A, Crystal Structure Of Human Cyclin B1
pdb|2B9R|B Chain B, Crystal Structure Of Human Cyclin B1
Length = 269
Score = 33.1 bits (74), Expect = 0.52, Method: Compositional matrix adjust.
Identities = 47/182 (25%), Positives = 68/182 (37%), Gaps = 32/182 (17%)
Query: 60 LRKSYCTFLQDLGMRLKVPQVTIATAIIFCHRFFIRQSHAKNDRRTIATVCMFLAGKVEE 119
+R +L + M+ ++ Q T+ + RF S K + + MF+A K EE
Sbjct: 37 MRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNSVPKKMLQLVGVTAMFIASKYEE 96
Query: 120 T-PRPLKDVIIVSYEIIHKKDSTAPQRIRQQKEVYEQQKELILLGERVVLATLGFDLNVH 178
P + D V+ ++ +IRQ E +L L F L
Sbjct: 97 MYPPEIGDFAFVT------DNTYTKHQIRQM--------------EMKILRALNFGLGRP 136
Query: 179 HPYKPLVEA--IKKFKVAQNALAQVAWNFVNDGLRTSL---CLQFKPHHIAAGAIFLAAK 233
P L A I + V Q+ LA+ T L + F P IAAGA LA K
Sbjct: 137 LPLHFLRRASKIGEVDVEQHTLAKYLMEL------TMLDYDMVHFPPSQIAAGAFSLALK 190
Query: 234 FL 235
L
Sbjct: 191 IL 192
>pdb|2JGZ|B Chain B, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 260
Score = 31.2 bits (69), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 54/215 (25%), Positives = 80/215 (37%), Gaps = 35/215 (16%)
Query: 29 EEVARWYFSRREIEDSSPSRRDGIDLKKETY--LRKSYCTFLQDLGMRLKVPQVTIATAI 86
E V Y R++E+ R + L +E +R +L + M+ ++ Q T+ +
Sbjct: 3 EYVKDIYAYLRQLEEEQAVRPKYL-LGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTV 61
Query: 87 IFCHRFFIRQSHAKNDRRTIATVCMFLAGKVEET-PRPLKDVIIVSYEIIHKKDSTAPQR 145
RF K + + MF+A K EE P + D V+ ++ +
Sbjct: 62 SIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVT------DNTYTKHQ 115
Query: 146 IRQQKEVYEQQKELILLGERVVLATLGFDLNVHHPYKPLVEA--IKKFKVAQNALAQVAW 203
IRQ E +L L F L P L A I + V Q+ LA+
Sbjct: 116 IRQM--------------EMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLM 161
Query: 204 NFVNDGLRTSL---CLQFKPHHIAAGAIFLAAKFL 235
T L + F P IAAGA LA K L
Sbjct: 162 EL------TMLDYDMVHFPPSQIAAGAFCLALKIL 190
>pdb|4GF5|A Chain A, Crystal Structure Of Calicheamicin Methyltransferase,
Cals11
pdb|4GF5|C Chain C, Crystal Structure Of Calicheamicin Methyltransferase,
Cals11
pdb|4GF5|E Chain E, Crystal Structure Of Calicheamicin Methyltransferase,
Cals11
pdb|4GF5|F Chain F, Crystal Structure Of Calicheamicin Methyltransferase,
Cals11
pdb|4GF5|H Chain H, Crystal Structure Of Calicheamicin Methyltransferase,
Cals11
pdb|4GF5|B Chain B, Crystal Structure Of Calicheamicin Methyltransferase,
Cals11
pdb|4GF5|D Chain D, Crystal Structure Of Calicheamicin Methyltransferase,
Cals11
pdb|4GF5|G Chain G, Crystal Structure Of Calicheamicin Methyltransferase,
Cals11
pdb|4GF5|I Chain I, Crystal Structure Of Calicheamicin Methyltransferase,
Cals11
pdb|4GF5|J Chain J, Crystal Structure Of Calicheamicin Methyltransferase,
Cals11
pdb|4GF5|K Chain K, Crystal Structure Of Calicheamicin Methyltransferase,
Cals11
pdb|4GF5|L Chain L, Crystal Structure Of Calicheamicin Methyltransferase,
Cals11
pdb|4GF5|M Chain M, Crystal Structure Of Calicheamicin Methyltransferase,
Cals11
pdb|4GF5|N Chain N, Crystal Structure Of Calicheamicin Methyltransferase,
Cals11
pdb|4GF5|O Chain O, Crystal Structure Of Calicheamicin Methyltransferase,
Cals11
pdb|4GF5|P Chain P, Crystal Structure Of Calicheamicin Methyltransferase,
Cals11
pdb|4GF5|Q Chain Q, Crystal Structure Of Calicheamicin Methyltransferase,
Cals11
pdb|4GF5|R Chain R, Crystal Structure Of Calicheamicin Methyltransferase,
Cals11
pdb|4GF5|S Chain S, Crystal Structure Of Calicheamicin Methyltransferase,
Cals11
pdb|4GF5|T Chain T, Crystal Structure Of Calicheamicin Methyltransferase,
Cals11
Length = 257
Score = 30.8 bits (68), Expect = 2.4, Method: Compositional matrix adjust.
Identities = 20/65 (30%), Positives = 31/65 (47%), Gaps = 5/65 (7%)
Query: 167 VLATLGFDLNVHHPYKPLVEAIKKFK-----VAQNALAQVAWNFVNDGLRTSLCLQFKPH 221
V+A FDL+++ P K ++EAI+ + VA + L W N +R L L P
Sbjct: 182 VIALAYFDLDLYEPTKAVLEAIRPYLTKGSIVAFDELDNPKWPGENIAMRKVLGLDHAPL 241
Query: 222 HIAAG 226
+ G
Sbjct: 242 RLLPG 246
>pdb|1VYW|B Chain B, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|D Chain D, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|B Chain B, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|D Chain D, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|B Chain B, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|D Chain D, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|B Chain B, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|D Chain D, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|B Chain B, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|D Chain D, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|B Chain B, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|D Chain D, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|B Chain B, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|D Chain D, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|B Chain B, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|D Chain D, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 265
Score = 29.6 bits (65), Expect = 5.3, Method: Compositional matrix adjust.
Identities = 21/85 (24%), Positives = 46/85 (54%), Gaps = 1/85 (1%)
Query: 184 LVEAIKKFKVAQNALAQVAWNFVNDGLRTSLCLQFKPHHIAAGAIFLAAKFLKVKLPSDG 243
LVE +++K+ QN +A N+++ L + L+ K + A+ LA+KF ++ P
Sbjct: 51 LVEVGEEYKL-QNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVA 109
Query: 244 DKVWWQEFDVTPRQLEEVSNQMLEL 268
+ V+ + T +Q+ + + +L++
Sbjct: 110 EFVYITDDTYTKKQVLRMEHLVLKV 134
>pdb|3S7Q|A Chain A, Crystal Structure Of A Monomeric Infrared Fluorescent
Deinococcus Radiodurans Bacteriophytochrome Chromophore
Binding Domain
Length = 343
Score = 29.3 bits (64), Expect = 6.6, Method: Compositional matrix adjust.
Identities = 34/132 (25%), Positives = 53/132 (40%), Gaps = 16/132 (12%)
Query: 114 AGKVEETPRPLKDVIIVSYEIIHKKDSTAPQRIRQQKEVYEQQKELILLGE---RVVLAT 170
AG + T + +++I+ +E DST P +R E L L E + V
Sbjct: 122 AGHLSLTVHRVGELLILEFEPTEAWDSTGPHALRNAMSALESAPNLRALAEVATQTVREL 181
Query: 171 LGFDLNVHHPYKPLVEAIKKFKVAQNALAQVAWNFVNDGLRTSLCLQFKPHHIAAGAIFL 230
GFD + +K A +A +V +GL L +F HI A A L
Sbjct: 182 TGFD------------RVMLYKFAPDATGEVIAEARREGLHAFLGHRFPASHIPAQARAL 229
Query: 231 AAKFLKVKLPSD 242
+ L ++L +D
Sbjct: 230 YTRHL-LRLTAD 240
>pdb|4BCQ|B Chain B, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 262
Score = 29.3 bits (64), Expect = 6.8, Method: Compositional matrix adjust.
Identities = 21/85 (24%), Positives = 46/85 (54%), Gaps = 1/85 (1%)
Query: 184 LVEAIKKFKVAQNALAQVAWNFVNDGLRTSLCLQFKPHHIAAGAIFLAAKFLKVKLPSDG 243
LVE +++K+ QN +A N+++ L + L+ K + A+ LA+KF ++ P
Sbjct: 48 LVEVGEEYKL-QNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVA 106
Query: 244 DKVWWQEFDVTPRQLEEVSNQMLEL 268
+ V+ + T +Q+ + + +L++
Sbjct: 107 EFVYITDDTYTKKQVLRMEHLVLKV 131
>pdb|3DOG|B Chain B, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|D Chain D, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 264
Score = 29.3 bits (64), Expect = 6.8, Method: Compositional matrix adjust.
Identities = 21/85 (24%), Positives = 46/85 (54%), Gaps = 1/85 (1%)
Query: 184 LVEAIKKFKVAQNALAQVAWNFVNDGLRTSLCLQFKPHHIAAGAIFLAAKFLKVKLPSDG 243
LVE +++K+ QN +A N+++ L + L+ K + A+ LA+KF ++ P
Sbjct: 48 LVEVGEEYKL-QNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVA 106
Query: 244 DKVWWQEFDVTPRQLEEVSNQMLEL 268
+ V+ + T +Q+ + + +L++
Sbjct: 107 EFVYITDDTYTKKQVLRMEHLVLKV 131
>pdb|1FIN|B Chain B, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|D Chain D, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1JSU|B Chain B, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FVV|B Chain B, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|D Chain D, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1OKV|B Chain B, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|D Chain D, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|B Chain B, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|D Chain D, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|B Chain B, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|D Chain D, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|B Chain B, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|D Chain D, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1URC|B Chain B, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|D Chain D, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|2C5O|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2CCH|B Chain B, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|D Chain D, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2I40|B Chain B, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|D Chain D, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|3EID|B Chain B, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|D Chain D, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|B Chain B, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|D Chain D, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|B Chain B, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|D Chain D, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2WEV|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
Length = 260
Score = 29.3 bits (64), Expect = 6.9, Method: Compositional matrix adjust.
Identities = 21/85 (24%), Positives = 46/85 (54%), Gaps = 1/85 (1%)
Query: 184 LVEAIKKFKVAQNALAQVAWNFVNDGLRTSLCLQFKPHHIAAGAIFLAAKFLKVKLPSDG 243
LVE +++K+ QN +A N+++ L + L+ K + A+ LA+KF ++ P
Sbjct: 46 LVEVGEEYKL-QNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVA 104
Query: 244 DKVWWQEFDVTPRQLEEVSNQMLEL 268
+ V+ + T +Q+ + + +L++
Sbjct: 105 EFVYITDDTYTKKQVLRMEHLVLKV 129
>pdb|1QMZ|B Chain B, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|D Chain D, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1H24|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|B Chain B, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|D Chain D, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2C5N|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2UUE|B Chain B, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|D Chain D, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|B Chain B, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|D Chain D, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2WMA|B Chain B, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|D Chain D, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|B Chain B, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|D Chain D, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 259
Score = 29.3 bits (64), Expect = 6.9, Method: Compositional matrix adjust.
Identities = 21/85 (24%), Positives = 46/85 (54%), Gaps = 1/85 (1%)
Query: 184 LVEAIKKFKVAQNALAQVAWNFVNDGLRTSLCLQFKPHHIAAGAIFLAAKFLKVKLPSDG 243
LVE +++K+ QN +A N+++ L + L+ K + A+ LA+KF ++ P
Sbjct: 45 LVEVGEEYKL-QNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVA 103
Query: 244 DKVWWQEFDVTPRQLEEVSNQMLEL 268
+ V+ + T +Q+ + + +L++
Sbjct: 104 EFVYITDDTYTKKQVLRMEHLVLKV 128
>pdb|3F5X|B Chain B, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|D Chain D, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
Length = 256
Score = 29.3 bits (64), Expect = 7.2, Method: Compositional matrix adjust.
Identities = 21/85 (24%), Positives = 46/85 (54%), Gaps = 1/85 (1%)
Query: 184 LVEAIKKFKVAQNALAQVAWNFVNDGLRTSLCLQFKPHHIAAGAIFLAAKFLKVKLPSDG 243
LVE +++K+ QN +A N+++ L + L+ K + A+ LA+KF ++ P
Sbjct: 42 LVEVGEEYKL-QNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVA 100
Query: 244 DKVWWQEFDVTPRQLEEVSNQMLEL 268
+ V+ + T +Q+ + + +L++
Sbjct: 101 EFVYITDDTYTKKQVLRMEHLVLKV 125
>pdb|2X1N|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
Length = 261
Score = 29.3 bits (64), Expect = 7.2, Method: Compositional matrix adjust.
Identities = 21/85 (24%), Positives = 46/85 (54%), Gaps = 1/85 (1%)
Query: 184 LVEAIKKFKVAQNALAQVAWNFVNDGLRTSLCLQFKPHHIAAGAIFLAAKFLKVKLPSDG 243
LVE +++K+ QN +A N+++ L + L+ K + A+ LA+KF ++ P
Sbjct: 47 LVEVGEEYKL-QNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVA 105
Query: 244 DKVWWQEFDVTPRQLEEVSNQMLEL 268
+ V+ + T +Q+ + + +L++
Sbjct: 106 EFVYITDDTYTKKQVLRMEHLVLKV 130
>pdb|4BCQ|D Chain D, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 262
Score = 29.3 bits (64), Expect = 7.3, Method: Compositional matrix adjust.
Identities = 21/85 (24%), Positives = 46/85 (54%), Gaps = 1/85 (1%)
Query: 184 LVEAIKKFKVAQNALAQVAWNFVNDGLRTSLCLQFKPHHIAAGAIFLAAKFLKVKLPSDG 243
LVE +++K+ QN +A N+++ L + L+ K + A+ LA+KF ++ P
Sbjct: 48 LVEVGEEYKL-QNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVA 106
Query: 244 DKVWWQEFDVTPRQLEEVSNQMLEL 268
+ V+ + T +Q+ + + +L++
Sbjct: 107 EFVYITDDTYTKKQVLRMEHLVLKV 131
>pdb|1OGU|B Chain B, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|D Chain D, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|2IW6|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW8|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW9|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 260
Score = 29.3 bits (64), Expect = 7.4, Method: Compositional matrix adjust.
Identities = 21/85 (24%), Positives = 46/85 (54%), Gaps = 1/85 (1%)
Query: 184 LVEAIKKFKVAQNALAQVAWNFVNDGLRTSLCLQFKPHHIAAGAIFLAAKFLKVKLPSDG 243
LVE +++K+ QN +A N+++ L + L+ K + A+ LA+KF ++ P
Sbjct: 46 LVEVGEEYKL-QNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVA 104
Query: 244 DKVWWQEFDVTPRQLEEVSNQMLEL 268
+ V+ + T +Q+ + + +L++
Sbjct: 105 EFVYITDDTYTKKQVLRMEHLVLKV 129
>pdb|1JST|B Chain B, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|D Chain D, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1GY3|B Chain B, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|D Chain D, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1H1P|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1P5E|B Chain B, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|D Chain D, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1PKD|B Chain B, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|D Chain D, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|2C6T|B Chain B, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|D Chain D, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|B Chain B, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|D Chain D, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CCI|B Chain B, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|D Chain D, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2UZB|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4EOI|B Chain B, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|D Chain D, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOJ|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOK|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOM|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EON|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOO|B Chain B, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|D Chain D, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOP|B Chain B, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|D Chain D, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOQ|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOR|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOS|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 258
Score = 28.9 bits (63), Expect = 7.7, Method: Compositional matrix adjust.
Identities = 21/85 (24%), Positives = 46/85 (54%), Gaps = 1/85 (1%)
Query: 184 LVEAIKKFKVAQNALAQVAWNFVNDGLRTSLCLQFKPHHIAAGAIFLAAKFLKVKLPSDG 243
LVE +++K+ QN +A N+++ L + L+ K + A+ LA+KF ++ P
Sbjct: 44 LVEVGEEYKL-QNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVA 102
Query: 244 DKVWWQEFDVTPRQLEEVSNQMLEL 268
+ V+ + T +Q+ + + +L++
Sbjct: 103 EFVYITDDTYTKKQVLRMEHLVLKV 127
>pdb|4BCO|B Chain B, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|D Chain D, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 262
Score = 28.9 bits (63), Expect = 7.7, Method: Compositional matrix adjust.
Identities = 21/85 (24%), Positives = 46/85 (54%), Gaps = 1/85 (1%)
Query: 184 LVEAIKKFKVAQNALAQVAWNFVNDGLRTSLCLQFKPHHIAAGAIFLAAKFLKVKLPSDG 243
LVE +++K+ QN +A N+++ L + L+ K + A+ LA+KF ++ P
Sbjct: 48 LVEVGEEYKL-QNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVA 106
Query: 244 DKVWWQEFDVTPRQLEEVSNQMLEL 268
+ V+ + T +Q+ + + +L++
Sbjct: 107 EFVYITDDTYTKKQVLRMEHLVLKV 131
>pdb|3DDQ|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
Length = 269
Score = 28.9 bits (63), Expect = 8.4, Method: Compositional matrix adjust.
Identities = 21/85 (24%), Positives = 46/85 (54%), Gaps = 1/85 (1%)
Query: 184 LVEAIKKFKVAQNALAQVAWNFVNDGLRTSLCLQFKPHHIAAGAIFLAAKFLKVKLPSDG 243
LVE +++K+ QN +A N+++ L + L+ K + A+ LA+KF ++ P
Sbjct: 48 LVEVGEEYKL-QNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVA 106
Query: 244 DKVWWQEFDVTPRQLEEVSNQMLEL 268
+ V+ + T +Q+ + + +L++
Sbjct: 107 EFVYITDDTYTKKQVLRMEHLVLKV 131
>pdb|3DDP|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
Length = 268
Score = 28.9 bits (63), Expect = 8.4, Method: Compositional matrix adjust.
Identities = 21/85 (24%), Positives = 46/85 (54%), Gaps = 1/85 (1%)
Query: 184 LVEAIKKFKVAQNALAQVAWNFVNDGLRTSLCLQFKPHHIAAGAIFLAAKFLKVKLPSDG 243
LVE +++K+ QN +A N+++ L + L+ K + A+ LA+KF ++ P
Sbjct: 48 LVEVGEEYKL-QNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVA 106
Query: 244 DKVWWQEFDVTPRQLEEVSNQMLEL 268
+ V+ + T +Q+ + + +L++
Sbjct: 107 EFVYITDDTYTKKQVLRMEHLVLKV 131
>pdb|3BHT|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|B Chain B, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|D Chain D, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|B Chain B, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|D Chain D, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
Length = 262
Score = 28.9 bits (63), Expect = 8.4, Method: Compositional matrix adjust.
Identities = 21/85 (24%), Positives = 46/85 (54%), Gaps = 1/85 (1%)
Query: 184 LVEAIKKFKVAQNALAQVAWNFVNDGLRTSLCLQFKPHHIAAGAIFLAAKFLKVKLPSDG 243
LVE +++K+ QN +A N+++ L + L+ K + A+ LA+KF ++ P
Sbjct: 48 LVEVGEEYKL-QNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVA 106
Query: 244 DKVWWQEFDVTPRQLEEVSNQMLEL 268
+ V+ + T +Q+ + + +L++
Sbjct: 107 EFVYITDDTYTKKQVLRMEHLVLKV 131
>pdb|2G9X|B Chain B, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|D Chain D, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
Length = 262
Score = 28.9 bits (63), Expect = 8.5, Method: Compositional matrix adjust.
Identities = 21/85 (24%), Positives = 46/85 (54%), Gaps = 1/85 (1%)
Query: 184 LVEAIKKFKVAQNALAQVAWNFVNDGLRTSLCLQFKPHHIAAGAIFLAAKFLKVKLPSDG 243
LVE +++K+ QN +A N+++ L + L+ K + A+ LA+KF ++ P
Sbjct: 48 LVEVGEEYKL-QNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVA 106
Query: 244 DKVWWQEFDVTPRQLEEVSNQMLEL 268
+ V+ + T +Q+ + + +L++
Sbjct: 107 EFVYITDDTYTKKQVLRMEHLVLKV 131
>pdb|1VIN|A Chain A, Bovine Cyclin A3
Length = 268
Score = 28.9 bits (63), Expect = 8.5, Method: Compositional matrix adjust.
Identities = 21/85 (24%), Positives = 46/85 (54%), Gaps = 1/85 (1%)
Query: 184 LVEAIKKFKVAQNALAQVAWNFVNDGLRTSLCLQFKPHHIAAGAIFLAAKFLKVKLPSDG 243
LVE +++K+ QN +A N+++ L + L+ K + A+ LA+KF ++ P
Sbjct: 48 LVEVGEEYKL-QNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVA 106
Query: 244 DKVWWQEFDVTPRQLEEVSNQMLEL 268
+ V+ + T +Q+ + + +L++
Sbjct: 107 EFVYITDDTYTKKQVLRMEHLVLKV 131
>pdb|1E9H|B Chain B, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|D Chain D, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
Length = 261
Score = 28.9 bits (63), Expect = 8.8, Method: Compositional matrix adjust.
Identities = 21/85 (24%), Positives = 46/85 (54%), Gaps = 1/85 (1%)
Query: 184 LVEAIKKFKVAQNALAQVAWNFVNDGLRTSLCLQFKPHHIAAGAIFLAAKFLKVKLPSDG 243
LVE +++K+ QN +A N+++ L + L+ K + A+ LA+KF ++ P
Sbjct: 44 LVEVGEEYKL-QNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVA 102
Query: 244 DKVWWQEFDVTPRQLEEVSNQMLEL 268
+ V+ + T +Q+ + + +L++
Sbjct: 103 EFVYITDDTYTKKQVLRMEHLVLKV 127
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.311 0.128 0.369
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 17,824,234
Number of Sequences: 62578
Number of extensions: 716971
Number of successful extensions: 1228
Number of sequences better than 100.0: 44
Number of HSP's better than 100.0 without gapping: 13
Number of HSP's successfully gapped in prelim test: 31
Number of HSP's that attempted gapping in prelim test: 1186
Number of HSP's gapped (non-prelim): 44
length of query: 601
length of database: 14,973,337
effective HSP length: 104
effective length of query: 497
effective length of database: 8,465,225
effective search space: 4207216825
effective search space used: 4207216825
T: 11
A: 40
X1: 16 ( 7.2 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 42 (21.8 bits)
S2: 54 (25.4 bits)